Developments in diagnosis and antileishmanial drugs. - Test2 - elhamkhani - TriplyDB

Developments in diagnosis and antileishmanial drugs.

Developments in diagnosis and antileishmanial drugs.

http://www.wikidata.org/entity/Q36355665

about

Alkyl galactofuranosides strongly interact with Leishmania donovani membrane and provide antileishmanial activity New trends in aminoglycosides use.Development of an Immunochromatographic Test for Diagnosis of Visceral Leishmaniasis Based on Detection of a Circulating Antigen.Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.Leishmaniases diagnosis: an update on the use of immunological and molecular tools.The in vitro biological activity of the Brazilian brown seaweed Dictyota mertensii against Leishmania amazonensis.Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis.Functional Involvement of Leishmania donovani Tryparedoxin Peroxidases during Infection and Drug Treatment.Clinical Efficacy Associated with Enhanced Antioxidant Enzyme Activities of Silver Nanoparticles Biosynthesized Using Moringa oleifera Leaf Extract, Against Cutaneous Leishmaniasis in a Murine Model of Leishmania major.In vitro screening of known drugs identified by scaffold hopping techniques shows promising leishmanicidal activity for suramin and netilmicin.Evaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in Bangladesh Synthesis and in vitro evaluation of leishmanicidal activity of 7-hydroxy-4-phenylcoumarin derivatives

P2860

Q33622864-EC040B08-D1A4-4AA9-BFD0-B7E4A97E2DB4 Q33951177-203BE173-B392-4AF8-B4E4-05A0B76E1F7B Q35678524-82446BF1-24B1-4393-ACFD-40ADB144E7AD Q36163680-F687C271-9A90-4490-9433-687B2742AD41 Q41147080-5587F1F4-D8FB-4F62-9036-4797538A3B7E Q41745007-3ACFE2CC-0A10-4B25-A36F-455072F54229 Q47229887-24DFB1D8-58EC-4850-BBFE-BA57E4357834 Q47735089-92EE2229-DAA5-4A49-B89A-B67B42746D6A Q54203083-6A2E7B09-E50D-4808-BE9C-F8EE1C2F8A08 Q55240622-560C6D42-D464-455C-A75D-6354F5A12C33 Q56463030-43869765-2B6E-4257-9F2D-4C08784CC9CE Q57963728-542C2F9C-99B0-4C7D-B698-33792E5359B7

P2860

Developments in diagnosis and antileishmanial drugs.

http://www.wikidata.org/entity/Q36355665

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Developments in diagnosis and antileishmanial drugs.

@ast

Developments in diagnosis and antileishmanial drugs.

@en

type

label

Developments in diagnosis and antileishmanial drugs.

@ast

Developments in diagnosis and antileishmanial drugs.

@en

prefLabel

Developments in diagnosis and antileishmanial drugs.

@ast

Developments in diagnosis and antileishmanial drugs.

@en

P1433

Q36355665-C88931FA-6FF9-4DF2-B2B0-8F671907258D

P1476

Q36355665-57F0B432-FF0C-4230-BDE4-1832B2036844

P2093

Q36355665-587142CD-51E0-4A17-890C-F19B96C12535

Q36355665-C25BA4C8-FB86-4A1A-BE23-2FE286974D08

P2860

Q36355665-0290CF6B-83DD-4927-95D6-9761A25FC44D

Q36355665-0397F20E-4E2F-4DD3-894E-89E12E93AEFD

Q36355665-0539860D-E65A-4613-A546-FA7DB76F9BEE

Q36355665-097F0EB5-42DF-4930-AEA5-E038A421195B

Q36355665-0B5F596C-A613-42E0-A3BC-888587A29792

Q36355665-0D3213B4-CA14-4F6B-9F09-0BE417B790C4

Q36355665-0E88B820-E46D-4F71-89F7-7E6D1A16EE27

Q36355665-0F4B176C-9D2B-4AAA-9E61-D6A831A3B856

Q36355665-1330D02F-7EAE-474A-9A12-D1B0A9951D7E

Q36355665-152CFDE4-11E1-4A79-99E0-87B5389E2234

P304

Q36355665-21A90C92-AE12-4E1A-89F5-764DD5DE6047

P31

Q36355665-018AE759-1479-469A-8FF5-768618F4ADD4

P356

Q36355665-6CBECED4-555B-453B-A943-0C16374DD266

P478

Q36355665-434B02FE-4838-4A04-AFC7-8CADC0CD4CFE

P577

Q36355665-AB5E9C56-077F-4693-9222-8A2DC9A53DB1

P5875

Q36355665-E741023D-D295-4F3C-972B-32D2814A8216

P698

Q36355665-14A17937-6AD4-4E08-ACB3-15A40BF578B0

P932

Q36355665-E4C2C128-63A5-4B21-9C75-FEE394E0CFF1

P356

P1433

Interdisciplinary Perspectives on Infectious Diseases

P1476

Developments in diagnosis and antileishmanial drugs.

@en

P2093

Prachi Bhargava

http://www.w3.org/2001/XMLSchema#string

Rajni Singh

http://www.w3.org/2001/XMLSchema#string

P2860

Leishmaniasis worldwide and global estimates of its incidence

A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis

Leishmaniasis: current status of available drugs and new potential drug targets

Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate

The strange case of Leishmania chagasi

Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress

Neglected tropical diseases

Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test

Reactive oxygen species production and mitochondrial dysfunction contribute to quercetin induced death in Leishmania amazonensis

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

P304

626838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/626838

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232766539

http://www.w3.org/2001/XMLSchema#string

P698

23118748

http://www.w3.org/2001/XMLSchema#string

P932

3483814

http://www.w3.org/2001/XMLSchema#string